Use the Back button in your browser to see the other results of your search or to select another record.
| Effect of treadmill ambulatory training on glucose control and blood pressure in persons with type 2 diabetes: a pilot study |
| Abonie US, Addo RA, Kumah L, Ofori-Ampomah AK, Makinyi V |
| PloS ONE 2024 Apr;19(4):e0298179 |
| clinical trial |
| 6/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
|
BACKGROUND: Lack of time is often cited by persons with type 2 diabetes for non-participation in regular exercise. This highlights the need to explores ways to help persons with type 2 diabetes to engage in an active lifestyle. This study evaluated the effect of a short duration norm intensity exercise on blood glucose and blood pressure in persons with type 2 diabetes. METHODS: Twenty persons with type 2 diabetes were randomly assigned to either training group (n = 10) or control group (n = 10). The training group received 4-weeks ambulatory training on a motor-driven treadmill (2 x 20 min per week at 60% target heart rate). The control group received no training. Blood glucose, and systolic and diastolic blood pressures were assessed before and after the 4-weeks training. Repeated measures ANOVA were used to examine training effect. RESULTS: Training significantly improved blood glucose (mean difference -2.73; p = 0.03). No effects were found for systolic blood pressure (mean difference -0.30; p = 0.96) and diastolic blood pressure (mean difference -0.90; p = 0.82). CONCLUSION: Training improved blood glucose but not blood pressure. A short-duration ambulatory training is an appropriate exercise mode to elicit beneficial effect, and exercise adoption in persons with type 2 diabetes. TRIAL REGISTRATION: This pilot trial is registered with the Pan African Clinical Trial Registry at pactr.samrc.ac.za (PACTR202306601940612).
|